MYC and neoplasm: Acting as a tumor-suppressor, miRNA-34 members modulate the p53 pathway by targeting c-MYC, CDK6, and c-MET, and therefore affect proliferation, apoptosis, and invasion in many cancer types, including pancreas, prostate, brain, colon, and breast cancer [80,88,89,90,91].